Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Journal of Immunological Methods
|
February 27, 2001
Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu
L D Lewis, B F Cole, P K Wallace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors
M J Glantz, K A Jaeckle, M C Chamberlain, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 24, 2001
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu
T Schwaab, L D Lewis, B F Cole, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
P Karlsson, B F Cole, B H Chua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
G Gruber, B F Cole, M Castiglione-Gertsch, et al.
Breast Cancer Research and Treatment
|
December 6, 2013
Symptoms of endocrine treatment and outcome in the BIG 1-98 study
J Huober, B F Cole, M Rabaglio, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Journal of Immunological Methods
|
February 27, 2001
Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu
L D Lewis, B F Cole, P K Wallace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors
M J Glantz, K A Jaeckle, M C Chamberlain, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 24, 2001
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu
T Schwaab, L D Lewis, B F Cole, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
P Karlsson, B F Cole, B H Chua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
G Gruber, B F Cole, M Castiglione-Gertsch, et al.
Breast Cancer Research and Treatment
|
December 6, 2013
Symptoms of endocrine treatment and outcome in the BIG 1-98 study
J Huober, B F Cole, M Rabaglio, et al.
Page
of 6